• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Dr Michael Thorpy on Diagnostic, Therapeutic Implications of Chronic Insomnia for Clinicians

Video

Michael Thorpy, MD, director, Sleep-Wake Disorders Center, Montefiore, and professor of neurology, Albert Einstein College of Medicine, discusses treatment implications for clinicians managing chronic insomnia and potential comorbid conditions.

Clinicians need to understand the significance of insomnia, how it’s affecting the patient, and whether there are other conditions that need to be treated along with the insomnia, said Michael Thorpy, MD, director, Sleep-Wake Disorders Center, Montefiore, and professor of neurology, Albert Einstein College of Medicine.


Transcript

What knowledge gaps among clinicians continue to impact diagnosis and treatment of chronic insomnia?

Well, I think the important thing is to recognize if insomnia is existing by itself or whether it's comorbid with other disorders. Most often it is comorbid with some other disorder, particularly a psychiatric or a medical disorder. So, clinicians really need to understand the significance of insomnia, how it’s affecting the patient, and whether there are other conditions that need to be treated along with the insomnia.

Too often people will see somebody who has a medical or psychiatric disorder and think that the primary treatment of the medical or the psychiatric disorder will eliminate the sleep disturbance, but usually it doesn't. You need to treat both at once—both the insomnia and the underlying medical or psychiatric disorder.

Related Videos
Most employees are unprepared to shop for coverage on their own, underscoring the need for stronger decision tools and consumer protections.
Experts warn that ICHRAs could either stabilize or destabilize the individual market, depending on which workers employers shift into these plans.
Aleata Postell, SVP of pharmacy business development, CenterWell Pharmacy
ASCO GI 2026 Recap
Jo Varshney, PhD, DVM, CEO and founder of VeriSIM Life
Dr Marco del Riccio
Bhavana (Tina) Bhatnagar, DO, West Virginia University Cancer Institute at Wheeling Hospital
Dr Debra Patt
Dr Marco del Riccio
Where patients live may shape outcomes in hypertrophic cardiomyopathy, with SDOH linked to higher risks of heart failure and arrhythmias.
© 2026 MJH Life Sciences
AJMC®
All rights reserved.